Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Hodgkins

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
British Journal of Nursing (Mark Allen Publishing)|November 1, 2021
Providing community intravenous therapy during the COVID-19 pandemicPaul Hodgkins
European Child & Adolescent Psychiatry|June 10, 2015
Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controlsDavid Coghill, Paul Hodgkins
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 7, 2014
The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX ® formulated delayed-release mesalamineAaron Yarlas, Linnette Yen, Paul Hodgkins
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|March 9, 2017
Community intravenous therapy provisionSue O'Hanlon, Pam McGrail, Paul Hodgkins
Current Medical Research and Opinion|September 25, 2010
Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the NetherlandsRahul Sasané, Paul Hodgkins, Willemijn Meijer
Clinical Therapeutics|April 19, 2011
Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the NetherlandsPaul Hodgkins, Rahul Sasané, Willemijn M Meijer
Clinicoeconomics and Outcomes Research : CEOR|August 22, 2014
Economic burden associated with chronic constipation in Sweden: a retrospective cohort studySara Bruce Wirta, Paul Hodgkins, Alain Joseph
BMC Gastroenterology|February 1, 2013
Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ databaseJean Lachaine, Linnette Yen, Catherine Beauchemin, et al.
Health and Quality of Life Outcomes|May 16, 2012
Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative studyMeryl Brod, Betsy Pohlman, Robert Lasser, et al.
European Child & Adolescent Psychiatry|July 6, 2012
Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment optionsPaul Hodgkins, Monica Shaw, David Coghill, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
British Journal of Nursing (Mark Allen Publishing)|November 1, 2021
Providing community intravenous therapy during the COVID-19 pandemicPaul Hodgkins
European Child & Adolescent Psychiatry|June 10, 2015
Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controlsDavid Coghill, Paul Hodgkins
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 7, 2014
The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX ® formulated delayed-release mesalamineAaron Yarlas, Linnette Yen, Paul Hodgkins
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|March 9, 2017
Community intravenous therapy provisionSue O'Hanlon, Pam McGrail, Paul Hodgkins
Current Medical Research and Opinion|September 25, 2010
Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the NetherlandsRahul Sasané, Paul Hodgkins, Willemijn Meijer
Clinical Therapeutics|April 19, 2011
Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the NetherlandsPaul Hodgkins, Rahul Sasané, Willemijn M Meijer
Clinicoeconomics and Outcomes Research : CEOR|August 22, 2014
Economic burden associated with chronic constipation in Sweden: a retrospective cohort studySara Bruce Wirta, Paul Hodgkins, Alain Joseph
BMC Gastroenterology|February 1, 2013
Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ databaseJean Lachaine, Linnette Yen, Catherine Beauchemin, et al.
Health and Quality of Life Outcomes|May 16, 2012
Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative studyMeryl Brod, Betsy Pohlman, Robert Lasser, et al.
European Child & Adolescent Psychiatry|July 6, 2012
Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment optionsPaul Hodgkins, Monica Shaw, David Coghill, et al.
Pageof 10